Medicared For All Logo

David Rhee in Great Neck, New York

Home New York Great Neck

David Rhee has Ophthalmology as his primary medical specialty. Their primary office is: 600 Northern Blvd in Great Neck, New York. There is an additional office location, for a total of two, for David Rhee that can be viewed further down.

They're a part of the: Long Island Vitreo Retinal Consultants Pc medical group which has around 18 members. You can call their office at 516-466-0390 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Un Of California, Irvine, College Of Medicine and graduated in 2003 (around 21 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


David Y Rhee Office Phone and Directions

David Rhee
Long Island Vitreo Retinal Consultants Pc
600 Northern Blvd
Great Neck, New York 11021
516-466-0390


Patient Ratings
Please rate your experience with David Rhee below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 516-466-0390


Enter a starting address:


Healthcare Info for David Rhee

Medical School: Un Of California, Irvine, College Of Medicine
Graduation Year: 2003
The Primary Medical Specialty for David Rhee is listed as: Ophthalmology
Approximate Years of Experience: 21
PAC (PECOS ID)#: 1456452143
NPI #: 1417177569
NPI Created On: 04/30/2007
NPI Last Updated Listed as: 10/08/2021
Primary Taxonomy Code: 207W00000X
License Number:
MD431478
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish, French.


Services and Procedures include:

  1. Injection of drug into eye
  2. Removal of eye fluid (vitreous) between the lens and retina
  3. Removal of membrane from the retina
  4. Laser destruction of retinal growth, 1 or more sessions
  5. Ultrasound of eye disease, growth, or structure
  6. Eye and medical examination for diagnosis and treatment, established patient
  7. Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits
  8. Diagnostic imaging of retina
  9. Extended examination of eye with drawing of retina
  10. Extended examination of eye with drawing of optic nerve and surrounding area (macula)
  11. Imaging of blood vessels in back of eye using fluorescein dye
  12. Photography of the retina
  13. New patient office or other outpatient visit, typically 45 minutes
  14. Injection, aflibercept, 1 mg
  15. Injection, ranibizumab, 0.1 mg
  16. Injection, bevacizumab, 10 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792919651

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RETINA

Name of Drug #1: OZURDEX

Open Associated Drug #1: 0023-3348-07


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792919653

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RETINA

Name of Drug #1: OZURDEX

Open Associated Drug #1: 0023-3348-07


Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835903745

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Ophthalmology

Name of Drug #1: Lucentis

Open Associated Drug #1: 50242-080-01


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835903739

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Ophthalmology

Name of Drug #1: Lucentis

Open Associated Drug #1: 50242-080-01


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Ownership Interest: Yes

Third party is a Charity:: No

Record ID:: 835903743

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Ophthalmology

Name of Drug #1: Lucentis

Open Associated Drug #1: 50242-080-01


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813198783

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: OPHTHALMOLOGY

Name of Drug #1: BEOVU

Open Associated Drug #1: 0078-0827-99


Payments Total: $19

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 809617623

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: OPHTHALMOLOGY

Name of Drug #1: EYLEA

Open Associated Drug #1: 61755-005-02


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 809617625

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: OPHTHALMOLOGY

Name of Drug #1: EYLEA

Open Associated Drug #1: 61755-005-02


Payments Total: $29

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 809617627

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: OPHTHALMOLOGY

Name of Drug #1: EYLEA

Open Associated Drug #1: 61755-005-02


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 809617629

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: OPHTHALMOLOGY

Name of Drug #1: EYLEA

Open Associated Drug #1: 61755-005-02


Additional Office Locations

1. Long Island Vitreo Retinal Consultants Pc
64 N Long Beach Rd
Rockville Centre, NY 11570
Group Members: 18

Phone: 516-466-0390

Enter a starting address:


Ophthalmology Professionals in Great Neck

600 Northern Blvd
Great-neck, NY
Long Island Vitreo Retinal Consultants Pc

600 Northern Blvd
Great-neck, NY
Long Island Vitreo Retinal Consultants Pc

26 Pine Dr
Great-neck, NY

935 Northern Blvd
Great-neck, NY

600 Northern Blvd
Great-neck, NY
Long Island Vitreo Retinal Consultants Pc

600 Northern Blvd
Great-neck, NY
Long Island Vitreo Retinal Consultants Pc

Providers in Long Island Vitreo Retinal Consultants Pc

1.Steven Bodine Md

915 Palmer Rd
Bronxville Ny 10708-3304
Long Island Vitreo Retinal Consultants Pc
Ophthalmology

2.Steven Bodine Md

17 Squadron Blvd
New City Ny 10956-5271
Long Island Vitreo Retinal Consultants Pc
Ophthalmology

3.Vincent Deramo Md

600 Northern Blvd
Great Neck Ny 11021-5200
Long Island Vitreo Retinal Consultants Pc
Ophthalmology

4.Vincent Deramo Md

200 Motor Pkwy
Hauppauge Ny 11788-5100
Long Island Vitreo Retinal Consultants Pc
Ophthalmology

5.David Fastenberg Md

600 Northern Blvd
Great Neck Ny 11021-5200
Long Island Vitreo Retinal Consultants Pc
Ophthalmology

6.David Fastenberg Md

200 Motor Pkwy
Hauppauge Ny 11788-5100
Long Island Vitreo Retinal Consultants Pc
Ophthalmology

View all 18 members of Long Island Vitreo Retinal Consultants Pc medical group